Word

MTM LABORATORIES

Status

Dead

Status Code

710

Status Date

Friday, April 18, 2014

Serial Number

78668046

Registration Number

3290364

Registration Date

Tuesday, September 11, 2007

Mark Type

4000

Filing Date

Tuesday, July 12, 2005

Published for Opposition

Tuesday, June 26, 2007

Cancellation Date

Friday, April 18, 2014

Trademark Owner History

ROCHE MTM LABORATORIES AG -
MTM Laboratories AG - Original Registrant

Classifications

1 Diagnostic preparations, reagents and chemical test kits for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant conditions, malignant conditions, cancer and inborn errors for scientific or research use

5 Pharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents and kits, comprising of medical diagnostic reagents and assays, for detection of cancer and neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn errors; medical diagnostic preparations namely in-vitro and in-vivo diagnostic test kits, comprising of medical diagnostic reagents and assays, diagnostic liquid-immuno-assay kits, comprising of medical diagnostic reagents and assays, diagnostic solid-phase immuno-assay kits, comprising of medical diagnostic reagents and assays, diagnostic strip-tests, comprising of medical diagnostic reagents and assays, diagnostic dip-stick-tests, comprising of medical diagnostic reagents and assays, point of care tests, comprising of medical diagnostic reagents and assays, diagnostic lateral-flow assay kits, comprising of medical diagnostic reagents and assays, diagnostic flow-through assay kits, comprising of medical diagnostic reagents and assays, diagnostic immuno-chromatographic kits, comprising of medical diagnostic reagents and assays; diagnostic equipment namely medical diagnostic test strips for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases, cotton, wood, and plastic sticks, cotton swabs and tampons for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases; therapeutic compounds and substances, namely, vaccines for prevention and treatment of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases

9 Diagnostic equipment, namely, plates having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; diagnostic equipment, namely, chromatography columns and clothing for use in laboratories for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases

10 Point-of-care testing machines, namely, for immunochemistry testing, medical diagnostic liquid-immuno-assay machines, medical diagnostic solid-phase immuno assay machines, medical diagnostic ELISA testing machines, medical diagnostic immuno-chromatographic machines; diagnostic equipment, namely containers for medical samples, vessels, namely, containers specially designed for storing and transporting medical samples, test tubes, namely, for medical samples and medical diagnostic testing, brushes, namely, for sampling of medical samples from body cavities and epithelia, medical syringes, needles for medical use, spatulas, namely, for medical samples and medical diagnostic testing, all for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases; diagnostic nucleic acid detection machines, diagnostic nucleic acid amplification machines, diagnostic immuno-histology machines and diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases

42 Scientific analysis in the fields of chemistry, biology and molecular biology, laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceuticals, chemistry, medical diagnostics and food technology; pharmaceutical research services, chemical research services and medical diagnostic research services for clinical, therapeutic, prophylactic and medical diagnostic applications and procedures; research and development of pharmaceutical products and substances for others; providing information on the subject of scientific research in the field of biochemistry, disease related molecular markers and molecular diagnostics; chemical, biological, molecular biology and pharmacogenomic analysis services

44 Medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors, detection of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; detection of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases; premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds

Color is not claimed as a feature of the mark.
"LABORATORIES"

Trademark Events

Apr 18, 2014

Cancelled Sec. 8 (6-Yr)

Mar 24, 2014

Withdrawal Of Attorney Granted

Mar 24, 2014

Teas Withdrawal Of Attorney Received

Apr 20, 2012

Attorney Revoked And/Or Appointed

Apr 20, 2012

Teas Revoke/Appoint Attorney Received

Apr 18, 2012

Automatic Update Of Assignment Of Ownership

Sep 11, 2007

Registered-Principal Register

Jun 26, 2007

Published For Opposition

Jun 6, 2007

Notice Of Publication

Apr 23, 2007

Law Office Publication Review Completed

Apr 18, 2007

Approved For Pub - Principal Register

Apr 17, 2007

Examiner's Amendment Entered

Apr 17, 2007

Assigned To Lie

Apr 16, 2007

Examiners Amendment E-Mailed

Apr 16, 2007

Examiners Amendment -Written

Mar 22, 2007

Teas/Email Correspondence Entered

Mar 21, 2007

Correspondence Received In Law Office

Mar 21, 2007

Teas Response To Office Action Received

Sep 21, 2006

Non-Final Action E-Mailed

Sep 21, 2006

Non-Final Action Written

Aug 31, 2006

Teas/Email Correspondence Entered

Aug 7, 2006

Correspondence Received In Law Office

Aug 7, 2006

Teas Response To Office Action Received

Aug 4, 2006

Teas Change Of Correspondence Received

Feb 15, 2006

Non-Final Action E-Mailed

Feb 15, 2006

Non-Final Action Written

Feb 1, 2006

Assigned To Examiner

Jul 18, 2005

New Application Entered In Tram